The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Immunofluorescence Assays Market Research Report 2025
Synopsis
Immunofluorescence is the specific antigen and antibody reaction where the antibodies are labeled with a fluorescent dye and the antigen-antibody complex is visualized using fluorescent (UV) microscope. Some of the commonly used fluorochromes include Acridine Orange, Lissamine, Rhodamine, and Calcofluor white. Various factors determine the type of immunofluorescence assay used such as time consumed, cost, complexity, flexibility, sensitivity, cross reactivity and many others. It is used in all disciplines of biology including medicine for diagnostics and research. Immunofluorescence assays are used to detect specific proteins in cells that may be in specimen, in culture, in tissues, on microbeads and microarrays, etc.
The global Immunofluorescence Assays market was valued at US$ 1678.4 million in 2023 and is anticipated to reach US$ 2196.9 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
North American market for Immunofluorescence Assays is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Immunofluorescence Assays is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Immunofluorescence Assays in Clinical Research is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Immunofluorescence Assays include Thermo Fisher, Inova Diagnostics, Bio-Rad, Abcam, PerkinELmer, Merck Millipore, Cell Signaling Technology, MEDIPAN GMBH and Sino Biological, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Immunofluorescence Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunofluorescence Assays.
Report Scope
The Immunofluorescence Assays market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immunofluorescence Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immunofluorescence Assays companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
Inova Diagnostics
Bio-Rad
Abcam
PerkinELmer
Merck Millipore
Cell Signaling Technology
MEDIPAN GMBH
Sino Biological
Danaher
Vector Laboratories
Segment by Type
Antibodies
Kits and Reagents
Labeling Dyes
Segment by Application
Clinical Research
Laboratory Diagnostics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunofluorescence Assays companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Immunofluorescence is the specific antigen and antibody reaction where the antibodies are labeled with a fluorescent dye and the antigen-antibody complex is visualized using fluorescent (UV) microscope. Some of the commonly used fluorochromes include Acridine Orange, Lissamine, Rhodamine, and Calcofluor white. Various factors determine the type of immunofluorescence assay used such as time consumed, cost, complexity, flexibility, sensitivity, cross reactivity and many others. It is used in all disciplines of biology including medicine for diagnostics and research. Immunofluorescence assays are used to detect specific proteins in cells that may be in specimen, in culture, in tissues, on microbeads and microarrays, etc.
The global Immunofluorescence Assays market was valued at US$ 1678.4 million in 2023 and is anticipated to reach US$ 2196.9 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
North American market for Immunofluorescence Assays is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Immunofluorescence Assays is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Immunofluorescence Assays in Clinical Research is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Immunofluorescence Assays include Thermo Fisher, Inova Diagnostics, Bio-Rad, Abcam, PerkinELmer, Merck Millipore, Cell Signaling Technology, MEDIPAN GMBH and Sino Biological, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Immunofluorescence Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunofluorescence Assays.
Report Scope
The Immunofluorescence Assays market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immunofluorescence Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immunofluorescence Assays companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
Inova Diagnostics
Bio-Rad
Abcam
PerkinELmer
Merck Millipore
Cell Signaling Technology
MEDIPAN GMBH
Sino Biological
Danaher
Vector Laboratories
Segment by Type
Antibodies
Kits and Reagents
Labeling Dyes
Segment by Application
Clinical Research
Laboratory Diagnostics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunofluorescence Assays companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunofluorescence Assays Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antibodies
1.2.3 Kits and Reagents
1.2.4 Labeling Dyes
1.3 Market by Application
1.3.1 Global Immunofluorescence Assays Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical Research
1.3.3 Laboratory Diagnostics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immunofluorescence Assays Market Perspective (2019-2030)
2.2 Immunofluorescence Assays Growth Trends by Region
2.2.1 Global Immunofluorescence Assays Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Immunofluorescence Assays Historic Market Size by Region (2019-2024)
2.2.3 Immunofluorescence Assays Forecasted Market Size by Region (2025-2030)
2.3 Immunofluorescence Assays Market Dynamics
2.3.1 Immunofluorescence Assays Industry Trends
2.3.2 Immunofluorescence Assays Market Drivers
2.3.3 Immunofluorescence Assays Market Challenges
2.3.4 Immunofluorescence Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immunofluorescence Assays Players by Revenue
3.1.1 Global Top Immunofluorescence Assays Players by Revenue (2019-2024)
3.1.2 Global Immunofluorescence Assays Revenue Market Share by Players (2019-2024)
3.2 Global Immunofluorescence Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immunofluorescence Assays Revenue
3.4 Global Immunofluorescence Assays Market Concentration Ratio
3.4.1 Global Immunofluorescence Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunofluorescence Assays Revenue in 2023
3.5 Immunofluorescence Assays Key Players Head office and Area Served
3.6 Key Players Immunofluorescence Assays Product Solution and Service
3.7 Date of Enter into Immunofluorescence Assays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunofluorescence Assays Breakdown Data by Type
4.1 Global Immunofluorescence Assays Historic Market Size by Type (2019-2024)
4.2 Global Immunofluorescence Assays Forecasted Market Size by Type (2025-2030)
5 Immunofluorescence Assays Breakdown Data by Application
5.1 Global Immunofluorescence Assays Historic Market Size by Application (2019-2024)
5.2 Global Immunofluorescence Assays Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Immunofluorescence Assays Market Size (2019-2030)
6.2 North America Immunofluorescence Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Immunofluorescence Assays Market Size by Country (2019-2024)
6.4 North America Immunofluorescence Assays Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immunofluorescence Assays Market Size (2019-2030)
7.2 Europe Immunofluorescence Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Immunofluorescence Assays Market Size by Country (2019-2024)
7.4 Europe Immunofluorescence Assays Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immunofluorescence Assays Market Size (2019-2030)
8.2 Asia-Pacific Immunofluorescence Assays Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Immunofluorescence Assays Market Size by Region (2019-2024)
8.4 Asia-Pacific Immunofluorescence Assays Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immunofluorescence Assays Market Size (2019-2030)
9.2 Latin America Immunofluorescence Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Immunofluorescence Assays Market Size by Country (2019-2024)
9.4 Latin America Immunofluorescence Assays Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immunofluorescence Assays Market Size (2019-2030)
10.2 Middle East & Africa Immunofluorescence Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Immunofluorescence Assays Market Size by Country (2019-2024)
10.4 Middle East & Africa Immunofluorescence Assays Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Detail
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Immunofluorescence Assays Introduction
11.1.4 Thermo Fisher Revenue in Immunofluorescence Assays Business (2019-2024)
11.1.5 Thermo Fisher Recent Development
11.2 Inova Diagnostics
11.2.1 Inova Diagnostics Company Detail
11.2.2 Inova Diagnostics Business Overview
11.2.3 Inova Diagnostics Immunofluorescence Assays Introduction
11.2.4 Inova Diagnostics Revenue in Immunofluorescence Assays Business (2019-2024)
11.2.5 Inova Diagnostics Recent Development
11.3 Bio-Rad
11.3.1 Bio-Rad Company Detail
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Immunofluorescence Assays Introduction
11.3.4 Bio-Rad Revenue in Immunofluorescence Assays Business (2019-2024)
11.3.5 Bio-Rad Recent Development
11.4 Abcam
11.4.1 Abcam Company Detail
11.4.2 Abcam Business Overview
11.4.3 Abcam Immunofluorescence Assays Introduction
11.4.4 Abcam Revenue in Immunofluorescence Assays Business (2019-2024)
11.4.5 Abcam Recent Development
11.5 PerkinELmer
11.5.1 PerkinELmer Company Detail
11.5.2 PerkinELmer Business Overview
11.5.3 PerkinELmer Immunofluorescence Assays Introduction
11.5.4 PerkinELmer Revenue in Immunofluorescence Assays Business (2019-2024)
11.5.5 PerkinELmer Recent Development
11.6 Merck Millipore
11.6.1 Merck Millipore Company Detail
11.6.2 Merck Millipore Business Overview
11.6.3 Merck Millipore Immunofluorescence Assays Introduction
11.6.4 Merck Millipore Revenue in Immunofluorescence Assays Business (2019-2024)
11.6.5 Merck Millipore Recent Development
11.7 Cell Signaling Technology
11.7.1 Cell Signaling Technology Company Detail
11.7.2 Cell Signaling Technology Business Overview
11.7.3 Cell Signaling Technology Immunofluorescence Assays Introduction
11.7.4 Cell Signaling Technology Revenue in Immunofluorescence Assays Business (2019-2024)
11.7.5 Cell Signaling Technology Recent Development
11.8 MEDIPAN GMBH
11.8.1 MEDIPAN GMBH Company Detail
11.8.2 MEDIPAN GMBH Business Overview
11.8.3 MEDIPAN GMBH Immunofluorescence Assays Introduction
11.8.4 MEDIPAN GMBH Revenue in Immunofluorescence Assays Business (2019-2024)
11.8.5 MEDIPAN GMBH Recent Development
11.9 Sino Biological
11.9.1 Sino Biological Company Detail
11.9.2 Sino Biological Business Overview
11.9.3 Sino Biological Immunofluorescence Assays Introduction
11.9.4 Sino Biological Revenue in Immunofluorescence Assays Business (2019-2024)
11.9.5 Sino Biological Recent Development
11.10 Danaher
11.10.1 Danaher Company Detail
11.10.2 Danaher Business Overview
11.10.3 Danaher Immunofluorescence Assays Introduction
11.10.4 Danaher Revenue in Immunofluorescence Assays Business (2019-2024)
11.10.5 Danaher Recent Development
11.11 Vector Laboratories
11.11.1 Vector Laboratories Company Detail
11.11.2 Vector Laboratories Business Overview
11.11.3 Vector Laboratories Immunofluorescence Assays Introduction
11.11.4 Vector Laboratories Revenue in Immunofluorescence Assays Business (2019-2024)
11.11.5 Vector Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
